- 专利标题： PYRIMIDINYL TYROSINE KINASE INHIBITORS
-
申请号： EP18171833.9申请日： 2013-06-07
-
公开(公告)号： EP3385263A1公开(公告)日： 2018-10-10
- 发明人: HOPKINS, Brian T. , CONLON, Patrick , CHAN, Timothy R. , JENKINS, Tracy J. , CAI, Xiongwei , HUMORA, Michael , SHI, Xianglin , MILLER, Ross A. , THOMPSON, Andrew
- 申请人： Biogen MA Inc. , Sunesis Pharmaceuticals, Inc.
- 申请人地址： 250 Binney Street Cambridge, MA 02142 US
- 专利权人： Biogen MA Inc.,Sunesis Pharmaceuticals, Inc.
- 当前专利权人： Biogen MA Inc.,Sunesis Pharmaceuticals, Inc.
- 当前专利权人地址： 250 Binney Street Cambridge, MA 02142 US
- 代理机构： Tostmann, Holger Carl
- 优先权： US201261657360P 20120608
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/435 ; A61K31/445 ; A61P37/00
摘要：
The present invention provides pyrimidinyl compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
公开/授权文献
- EP3385263B1 PYRIMIDINYL TYROSINE KINASE INHIBITORS 公开/授权日：2020-07-22
信息查询
